Prudential Financial
NUVB icon

Prudential Financial’s Nuvation Bio NUVB Stock Holding History

Prudential Financial’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$159K Buy
37,030
+22,740
+159% +$127K ﹤0.01% 2174
2025
Q4 		$128K Sell
14,290
-15,740
-52% -$97.5K ﹤0.01% 2106
2025
Q3 		$111K Buy
30,030
+1,125
+4% +$3.07K ﹤0.01% 2269
2025
Q2 		$56.4K Buy
28,905
+15,290
+112% +$31.8K ﹤0.01% 2335
2025
Q1 		$24K Buy
13,615
+1,400
+11% +$3.19K ﹤0.01% 2244
2024
Q4 		$32.5K Hold
12,215
– – ﹤0.01% 2248
2024
Q3 		$28K Hold
12,215
– – ﹤0.01% 2682
2024
Q2 		$35.7K Buy
+12,215
New +$37.3K ﹤0.01% 2646
2022
Q2 		– Sell
-10,105
Closed -$53K – 2729
2022
Q1 		$53K Hold
10,105
– – ﹤0.01% 2570
2021
Q4 		$86K Buy
+10,105
New +$92.9K ﹤0.01% 2583

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Prudential Financial's NUVB Position: Q1 2026 in Review

Prudential Financial increased its Nuvation Bio (NUVB) stake by 159% in Q1 2026, buying an estimated $127K and bringing the position to 37,030 shares worth $159K. The position accounts for ﹤0.01% of the portfolio, ranked #2174.

Prudential Financial first reported a position in NUVB in Q4 2021 and has held it in 10 quarters since. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Prudential Financial held 37,030 shares of Nuvation Bio worth $159K as of Q1 2026.
  • Prudential Financial bought 22,740 Nuvation Bio shares in Q1 2026, an estimated $127K.
  • Nuvation Bio made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #2174 holding.
  • Prudential Financial first reported a position in Nuvation Bio in Q4 2021 and has held it in 10 quarters since.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.